World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

PEMPHIGOID GESTATIONIS: DIAGNOSIS, FETAL PROGNOSIS AND TREATMENT: A CASE REPORT

J. Ouchraa*, K. Harou, H. Asmouki and A. Soumani

ABSTRACT

Pemphigoid Gestationis (PG) is a rare autoimmune dermatosis related to pregnancy, with an incidence of 1 in 20,000 to 50,000 pregnancies. it usually appears during the second and third trimesters, but can also occur at any stage of pregnancy and postpartum. Clinical manifestations of PG include intense pruritus, papules and annular plaques followed by vesicles and finally large, tense, bullae on an erythematous background that typically appear periumbilical and spread to the trunk and extremities. The diagnosis of PG is based on a deep clinical evaluation, the histological findings, direct and indirect immunofluorescence and the measurement of serum levels of anti BP180 antibodies using ELISA. PG can have an impact on pregnancy by increasing the risk of intrauterine growth restriction, prematurity and obstetric complications. We report the case of a 36-year-old multigravida, diagnosed with Pemphigoid Gestationis, in week 26 of gestation. The patient was treated successfully and delivered a healthy child without any symptoms of congenital pemphigus.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR